Procalcitonin as a biomarker for ventilator associated pneumonia in COVID-19 patients: Is it an useful stewardship tool?

Ventilator associated pneumonia(VAP) is a severe complication that can lead to high mortality when not early identified or when therapy is delayed. The aim of this study was to evaluate procalcitonin(PCT) as a biomarker for VAP development. In total, 73 hospitalized patients with COVID-19 were analy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Diagn Microbiol Infect Dis
Autors principals: Côrtes, Marina Farrel, de Almeida, Bianca Leal, Espinoza, Evelyn Patricia Sanchez, Campos, Aléia Faustina, do Nascimento Moura, Maria Luiza, Salomão, Matias C., Boszczowski, Icaro, Freire, Maristela Pinheiro, de Carvalho, Laina Bubach, Paranhos-Baccalà, Gláucia, Costa, Silvia Figueiredo, Guimarães, Thaís
Format: Artigo
Idioma:Inglês
Publicat: Elsevier Inc. 2021
Matèries:
Clinical Studies
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7879055/
https://ncbi.nlm.nih.gov/pubmed/34243136
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.diagmicrobio.2021.115344
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars